Nature of the Disclosure
Regulatory filing pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimating the receipt of listing approvals for equity shares issued on a preferential basis.
Key Quantitative Figures
The company has received approval for listing of 2,95,00,000 equity shares of Re.1/- each issued at a premium of Rs.1.80 per share. The distinctive numbers of these shares range from 191500001 to 221000000.
Dates of Action
- Date of Disclosure Letter: September 12, 2026
- Date of BSE Approval Letter: September 11, 2026 (Ref: LOD/PREF/MV/FIP/779/2026-27)
- Date of NSE Approval Letter: September 11, 2026 (Ref: NSE/LIST/56854)
Parties Involved
- Issuing Company: Viji Finance Limited
- Regulatory/Stock Exchanges: BSE Limited, National Stock Exchange of India Limited (NSE)
- Depositories: NSDL, CDSL (Central Depository Services Limited)
- Recipients of Shares: Non-promoters/Public Category
- Company Representatives: Vijay Kothari (Chairman & Managing Director, DIN: 00172878), Mayuri Visaria (Deputy Manager, BSE), Pooja Pashte (Manager, NSE)
Conditions for Trading Approval
Trading approval will be granted only after the company submits:
- Listing approval from NSE (if applicable)
- Confirmation letters from NSDL/CDSL about crediting shares to beneficiary accounts
- Confirmation letters from NSDL/CDSL about lock-in of pre-preferential holding (if applicable)
Timeline Requirements
The company must apply for trading approval within seven working days from the date of grant of listing approval (as per SEBI Circular dated June 21, 2023). Non-compliance will attract fines as specified in the circular.
Additional Requirements
The company must file shareholding pattern in XBRL mode if there is a change exceeding two percent of the total paid-up share capital.
Contingencies
The exchanges reserve the right to withdraw the in-principle approval if the information submitted is found to be incomplete, incorrect, misleading, false, or in contravention of any rules, regulations, or guidelines.